Ophthalmic Drugs and Pharmacology
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 1 May 2026 | Viewed by 40
Special Issue Editors
Interests: clinical sciences; ophthalmology and optometry; health services and systems
Interests: drug delivery; formulation; pharmacokinetics analysis
Special Issue Information
Dear Colleagues,
The field of ophthalmic pharmacology is continuing to evolve at a rapid pace, driven by advances in drug discovery, delivery technologies, and translational research. Ophthalmic diseases, including glaucoma, corneal disorders, retinal degeneration, ocular surface disease, and uveitis remain among the leading causes of visual impairment worldwide. Innovative pharmacological approaches are essential in addressing unmet needs, reducing the treatment burden, and improving patient outcomes.
This Special Issue of Pharmaceuticals, entitled “Ophthalmic Drugs and Pharmacology”, will bring together original research articles, reviews, and perspectives that highlight the latest scientific and clinical advances in this field. We invite contributions covering (but not limited to) the following topics:
- Novel drug development (small molecules, biologics, and gene- and cell-based therapies for ocular diseases);
- Drug delivery systems (sustained-release formulations, implants, nanotechnology, microneedles, and topical innovations);
- Repurposed therapies;
- Pharmacogenomics and precision medicine;
- Adverse drug reactions and pharmacovigilance in ophthalmic care;
- Health economics and patient perspectives on pharmacological treatments.
By bringing together interdisciplinary work from the fields of pharmaceutical sciences, clinical ophthalmology, and biomedical engineering, this Special Issue will foster dialogue between researchers, clinicians, and industry stakeholders, ultimately advancing the future of eye care.
We welcome submissions of original research papers, systematic reviews, short communications, and perspectives.
We look forward to your contributions to this exciting Special Issue, which will serve as a platform to showcase innovation and impacts in the pharmacological treatment of eye diseases.
Dr. Christin Henein
Dr. Sahar Awwad
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmic diseases
- optic neuropathies
- eye diseases
- glaucoma
- corneal disorders
- retinal degeneration
- ocular surface disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
